{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:05:15Z","timestamp":1792001115532,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007131","name":"Texas Tech University","doi-asserted-by":"publisher","award":["05.822"],"award-info":[{"award-number":["05.822"]}],"id":[{"id":"10.13039\/100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007131","name":"Texas Tech University","doi-asserted-by":"publisher","award":["05.820"],"award-info":[{"award-number":["05.820"]}],"id":[{"id":"10.13039\/100007131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jhep.2024.01.035","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T11:36:19Z","timestamp":1707392179000},"page":"882-891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1156-2320","authenticated-orcid":false,"given":"Lena","family":"Allweiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2847-717X","authenticated-orcid":false,"given":"Annika","family":"Volmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vithika","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5952-3813","authenticated-orcid":false,"given":"Jeffrey J.","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Manuilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8278-722X","authenticated-orcid":false,"given":"Bryan","family":"Downie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"L\u00fctgehetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Hendrik","family":"Bockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1560-8038","authenticated-orcid":false,"given":"Stephan","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2906-0480","authenticated-orcid":false,"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0073-6689","authenticated-orcid":false,"given":"Maura","family":"Dandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2024.01.035_bib1","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jhep.2022.05.022","article-title":"The hepatitis delta virus and chronic hepatitis D","volume":"77","author":"Dandri","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104812","article-title":"Current knowledge on hepatitis delta virus replication","volume":"179","author":"Lucifora","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhep.2024.01.035_bib3","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.jhep.2024.01.035_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/gutjnl-2017-314713","article-title":"Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in\u00a0vitro and in\u00a0vivo","volume":"68","author":"Giersch","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.01.035_bib5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2022.05.023","article-title":"Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread","volume":"77","author":"Zhang","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/v14020198","article-title":"Adaptive immune responses, immune escape and immune-mediated pathogenesis during HDV infection","volume":"14","author":"Oberhardt","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jhep.2024.01.035_bib8","article-title":"Interferon-based treatment of chronic hepatitis D","author":"Sandmann","year":"2022","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jhep.2024.01.035_bib9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa0912696","article-title":"Peginterferon plus adefovir versus either drug alone for hepatitis delta","volume":"364","author":"Wedemeyer","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2024.01.035_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cld.2021.06.011","article-title":"New treatments for chronic hepatitis B virus\/hepatitis D virus infection","volume":"25","author":"Sandmann","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2024.01.035_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL Clinical Practice Guidelines on hepatitis delta virus","author":"Brunetto","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib12","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/JVI.01902-09","article-title":"Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction","volume":"84","author":"Schulze","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2024.01.035_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nbt1389","article-title":"Prevention of hepatitis B virus infection in\u00a0vivo by entry inhibitors derived from the large envelope protein","volume":"26","author":"Petersen","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhep.2024.01.035_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation","volume":"55","author":"Lutgehetmann","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.035_bib15","article-title":"Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase II trial","volume":"0","author":"Wedemeyer","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2024.01.035_bib16","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2213429","article-title":"A\u00a0phase III, randomized trial of bulevirtide in chronic hepatitis D","author":"Wedemeyer","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2024.01.035_bib17","first-page":"26","article-title":"Bulevirtide-based treatment strategies for chronic hepatitis delta: a review","volume":"30","author":"Degasperi","year":"2023","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhep.2024.01.035_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(20)30651-6","article-title":"AS072 - 48 weeks of high dose (10 mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV\/HDV co-infection","volume":"73","author":"Wedemeyer","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2021.04.051","article-title":"Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load","volume":"75","author":"Meier","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2016.04.013","article-title":"First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B","volume":"65","author":"Blank","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jhep.2021.10.012","article-title":"Safety and effectiveness of up to 3 years\u2019 bulevirtide monotherapy in patients with HDV-related cirrhosis","volume":"76","author":"Loglio","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib22","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1016\/S0168-8278(22)00767-X","article-title":"Fate of HDV-specific CD8+ T cells during bulevirtide monotherapy in patients with chronic hepatitis delta","volume":"77","author":"Oberhardt","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep.1840130508","article-title":"Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen","volume":"13","author":"Cole","year":"1991","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jhep.2024.01.035_bib24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/v13050788","article-title":"AAV-HDV: an attractive platform for the in\u00a0vivo study of HDV biology and the mechanism of disease pathogenesis","volume":"13","author":"Maestro","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jhep.2024.01.035_bib25","article-title":"Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment","volume":"5","author":"Giersch","year":"2023","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib26","article-title":"Inducers of the NF-\u03baB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in\u00a0vitro","volume":"4","author":"Michelet","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2024.01.035_bib27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2013.11.010","article-title":"Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection","volume":"60","author":"Giersch","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhep.2011.06.016","article-title":"Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation","volume":"56","author":"Mederacke","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2024.01.035_bib29","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jhep.2022.12.023","article-title":"A 3-year course of bulevirtide monotherapy may cure hdv infection in cirrhotics","author":"Anolli","year":"2023","journal-title":"J Hepatol"},{"issue":"S1","key":"10.1016\/j.jhep.2024.01.035_bib30","first-page":"63","article-title":"Continued treatment of early virologic non-responder or partial responders with bulevirtide monotherapy for chronic hepatitis D leads to improvement in virologic and biochemical responses: results from an integrated analysis at week 96","volume":"78","author":"Lampertico","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.035_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.04.027","article-title":"No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta","author":"Hollnberger","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib32","article-title":"Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV\/HDV","volume":"5","author":"Mateo","year":"2023","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/JVI.01609-10","article-title":"Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses","volume":"85","author":"Pollicino","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2024.01.035_bib34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jhep.2009.10.036","article-title":"Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D","volume":"52","author":"Schaper","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"23","key":"10.1016\/j.jhep.2024.01.035_bib35","first-page":"16","article-title":"Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms","author":"Lucifora","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib36","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1128\/JVI.00430-14","article-title":"Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles","volume":"88","author":"Freitas","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2024.01.035_bib37","article-title":"Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B","volume":"4","author":"van Buuren","year":"2022","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.jhep.2024.01.035_bib38","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/jvh.13356","article-title":"Deep sequencing of liver explant transcriptomes reveals extensive expression from integrated hepatitis B virus DNA","volume":"27","author":"Ringlander","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhep.2024.01.035_bib39","article-title":"Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells","volume":"5","author":"Aggarwal","year":"2023","journal-title":"JHEP Rep Innov Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824001144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824001144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:30:17Z","timestamp":1728880217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827824001144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0168827824001144"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.01.035","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}